Specialist & Consultant Reproductive Medicine & Infertility oral assessment prep

Knowledge: She is a predicted high responder, with PCOS, high AMH, a large follicle cohort and high oestradiol. An hCG trigger would put her at high risk of moderate to severe OHSS. OHSS is driven by hCG through VEGF release, causing capillary leak, haemoconcentration and thrombosis risk. Early OHSS follows the trigger, while late OHSS follows pregnancy hCG and is usually more severe. Because she is in an antagonist cycle, a GnRH agonist trigger is possible and greatly reduces early OHSS. Freezing all embryos removes the risk of late OHSS, and ESHRE supports both measures in high responders.

Management: I would cancel the hCG and give a GnRH agonist trigger, for example triptorelin 0.2 mg, with retrieval 35 to 36 hours later. I would plan to vitrify all suitable embryos with no fresh transfer. After retrieval I would check her pain, abdomen and vital signs. She would leave with written warning signs: rapid weight gain, swelling, breathlessness and reduced urine, plus a direct unit number. I would review her within a few days, with haematocrit, electrolytes and ultrasound if symptomatic. I would not rely on coasting, cabergoline or albumin instead of a safer trigger. The frozen transfer would follow in a later cycle. I would also lower her FSH dose next time.

Ethics and communication: I would listen to the couple, but I must not expose her to a foreseeable, serious and avoidable harm. I would answer the friend's claim with the evidence in plain language. I would record the discussion and their consent to the revised plan. If they still insisted on hCG and a fresh transfer, I would decline and offer a second opinion. I would review the missed risk with the fellow as learning, not blame.

Reference: ESHRE Guideline: Ovarian Stimulation for IVF/ICSI, 2025 update; RCOG Green-top Guideline No. 5: The Management of Ovarian Hyperstimulation Syndrome, 2016

Knowledge: Normal-volume azoospermia with small testes and high FSH indicates primary testicular failure. The picture strongly suggests Klinefelter syndrome, most often 47,XXY. Obstruction is unlikely, so CFTR testing is not the priority. I would request a karyotype and Y chromosome microdeletion testing, because complete AZFa or AZFb deletions predict failed retrieval. Exogenous testosterone suppresses gonadotrophins and further reduces spermatogenesis, so it harms his fertility. Microdissection TESE is the preferred retrieval method, and sperm are found in roughly up to half of men with Klinefelter syndrome. He also needs long-term care for hypogonadism, bone and metabolic health.

Management: I would take a full history, including cryptorchidism, mumps, chemotherapy and sexual function, and examine for varicocele and the vasa. I would stop testosterone now and explain that recovery may take months. I would request karyotype, Y microdeletions, prolactin, oestradiol and a scrotal ultrasound to exclude a mass. I would assess his wife in parallel so no time is lost. With genetics known, I would refer him to an experienced micro-TESE surgeon, timed with her IVF cycle or with sperm cryopreservation. Medical optimisation before surgery has limited evidence, and I would say so. If retrieval fails, I would discuss only options lawful for them in the UAE. Endocrine follow-up continues afterwards.

Ethics and communication: I would give the genetic diagnosis to him privately and let him decide what to share, explaining why it matters for joint treatment. Infertility carries stigma in many families, so I would use non-blaming language and offer counselling. I would be honest that retrieval may fail and offer genetic counselling. Donor options are restricted under UAE law, so I would check the current amended position before advising.

Reference: EAU Guidelines on Sexual and Reproductive Health, European Association of Urology; WHO Laboratory Manual for the Examination and Processing of Human Semen, 6th edition, 2021

Knowledge: This is a heterotopic pregnancy with a probable ruptured right tubal ectopic until proven otherwise. It is rare after natural conception but much more common after IVF, especially with multiple embryo transfer and tubal disease. A live intrauterine pregnancy does not exclude an ectopic, and that false reassurance is the classic error. Serum hCG is unhelpful because the intrauterine pregnancy produces it. Tachycardia, falling haemoglobin and fluid in Morison's pouch mean significant haemoperitoneum. Methotrexate is contraindicated, and expectant care is unsafe. Tubal occlusion does not prevent implantation in the proximal tube.

Management: I would resuscitate her immediately with two large-bore cannulas and crossmatch, and call the anaesthetist. I would take her for urgent laparoscopy, or laparotomy if unstable, for right salpingectomy. I would avoid uterine manipulators and keep handling of the uterus gentle and brief. If the ectopic were interstitial, I would involve a surgeon experienced in that approach. I would check her blood group and give anti-D if she is Rh negative. Within a few days, ultrasound should confirm the intrauterine pregnancy remains viable. I would continue luteal support and arrange early pregnancy unit follow-up with direct contact details.

Ethics and communication: Consent must be informed but rapid. I would explain the internal bleeding, the need for surgery and that we will protect the pregnancy without guaranteeing it. Her husband may support her, but the consent is hers as a competent adult. I would document the discussion and the time. Later I would explain the link with double embryo transfer and recommend single embryo transfer.

Reference: NICE Guideline NG126: Ectopic Pregnancy and Miscarriage: Diagnosis and Initial Management; Speroff's Clinical Gynecologic Endocrinology and Infertility, 9th edition

Knowledge: Assisted reproduction in the UAE is regulated by Federal Decree-Law No. 7 of 2019 on Medically Assisted Reproduction, as amended, with emirate regulation and licence conditions. Use of a couple's embryos rests on both partners' informed written consent, valid at the time of use. A withdrawal before transfer means that consent no longer exists. The law also addresses storage and the fate of embryos when a relationship ends, and I would not guess those details. Cancelling the transfer causes no physical harm, because the embryos stay stored. The clinical decision is simple, and the real task is handling the conflict well.

Management: I would not proceed with the transfer. I would verify the caller's identity through centre procedure and ask for written confirmation. I would meet the wife privately, explain the consent requirement and acknowledge her loss. I would advise her on stopping her hormone preparation safely. I would keep the embryos stored unchanged and flag the dispute clearly in both files. I would inform the medical director and seek legal advice on the storage position. I would offer counselling to both, separately if needed. Any decision about the embryos would follow the law and a written agreement or ruling.

Ethics and communication: I would respect the husband's right to withdraw and the wife's right to dignity and the truth. I would keep each partner's information confidential and avoid taking sides. I would document the call, verification and conversations. This case also shows why consent forms should state clearly what happens to embryos on separation, divorce or death.

Reference: Federal Decree-Law No. 7 of 2019 on Medically Assisted Reproduction (as amended); Federal Decree-Law No. 4 of 2016 on Medical Liability

Knowledge: ESHRE defines recurrent pregnancy loss as two or more pregnancy losses, which she clearly meets. Persistent lupus anticoagulant and moderate-titre anticardiolipin, confirmed 12 weeks apart, with three early losses, meet criteria for obstetric antiphospholipid syndrome. Lupus anticoagulant is the strongest predictor of poor outcome. I would ask about previous thrombosis and features of lupus. Consanguinity raises the chance of recessive genetic causes, so tissue genetics and genetic counselling are relevant. The evidence-based treatment is low-dose aspirin with prophylactic low molecular weight heparin. Steroids, IVIG and immunotherapy have no role.

Management: I would explain the diagnosis and that most treated women go on to a live birth. I would start low-dose aspirin before conception. I would add prophylactic heparin, such as enoxaparin 40 mg daily, from a positive test until 6 weeks postpartum. I would check ANA, blood count and renal function, and refer to rheumatology if lupus features appear. I would arrange an early viability scan and consultant-led antenatal care with uterine artery Doppler and growth scans. If she bleeds in early pregnancy, vaginal progesterone can be considered. Any future pregnancy tissue should go for genetic testing. She must avoid oestrogen-containing contraception.

Ethics and communication: Where repeated loss brings family pressure, I would make clear that this is a treatable condition and not her fault. I would raise consanguinity sensitively and offer genetic counselling without judgement. I would share results with her husband only with her agreement. I would record her consent to heparin in pregnancy.

Reference: ESHRE Guideline: Recurrent Pregnancy Loss, 2022 update; EULAR Recommendations for the Management of Antiphospholipid Syndrome in Adults, 2019; NICE Guideline NG126: Ectopic Pregnancy and Miscarriage: Diagnosis and Initial Management

Knowledge: Vitrified material is stored near minus 196 C, and warming above the glass transition point risks ice crystal damage. Damage depends on peak temperature and duration, which are unknown, so viability cannot be assumed. Storage failures usually combine device failure with gaps in alarms, escalation and staffing. Good practice requires continuous monitoring with remote alarms, an escalation chain, manual checks, a spare dewar and an emergency plan. The oncology patients may have no further chance to produce gametes. Concealment would be an ethical and legal failure.

Management: I would have the dewar refilled at once, or its contents moved to a spare tank, without thawing anything. I would preserve the probe logs, alarm records, fill logs, rotas and the faulty device. I would report the incident that day and notify the licensing authority as UAE law and its requirements demand. I would form an incident team with the laboratory director, quality lead and legal advisor, and commission an independent root cause analysis. I would contact every affected patient personally, starting with the oncology patients, and offer a meeting. Before any use, I would discuss options such as a test warming, with consent. I would check every other dewar and alarm that day.

Ethics and communication: I would decline the suggestion firmly while recognising that fear of blame drives it. Open disclosure means an apology, the known facts and a promise to share findings. I would document every conversation. Possible claims mean involving the insurer, but that must not delay honest communication.

Reference: ESHRE Revised Guidelines for Good Practice in IVF Laboratories, 2015; Federal Decree-Law No. 4 of 2016 on Medical Liability